Alchemab Therapeutics

Company Deals

Alchemab Therapeutics Licenses ATLX-1282 to Eli Lilly for ALS Treatment

Fineline Cube May 7, 2025

UK-based biotech Alchemab Therapeutics Ltd entered into a licensing agreement with US major Eli Lilly...

Company Deals

Alchemab Therapeutics Partners with Eli Lilly to Discover ALS Treatments

Fineline Cube Jan 10, 2025

UK-based Alchemab Therapeutics has formed a strategic partnership with US major Eli Lilly & Co....

Company Drug

China Medical System’s Silvemimab Becomes World’s First Dual-Epitope Fully Human Rabies Antibody Approved in China

Company Deals

Fusen Pharmaceutical Secures RMB 300M Strategic Investment for Henan Subsidiary Debt Restructuring and Working Capital

Company Drug

Biokin Secures World’s First EGFR×HER3 Bispecific ADC Approval with Loncomystatug Deruxtecan for Nasopharyngeal Carcinoma

Policy / Regulatory

China Launches 12th National Drug Volume-Based Procurement Batch with 65 Products, Patent Disputes Highlighted